{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:27:21Z","timestamp":1793820441366,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-04046-x","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:32:00Z","timestamp":1760013120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thyroid disease and breast cancer, benign breast neoplasm: a two-sample Mendelian randomization study"],"prefix":"10.1186","volume":"25","author":[{"given":"Bowen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"3","key":"4046_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4046_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4046_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41568-020-0266-x","volume":"20","author":"KL Britt","year":"2020","unstructured":"Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20(8):417\u201336.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4046_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229\u201337.","journal-title":"N Engl J Med"},{"key":"4046_CR5","doi-asserted-by":"crossref","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146\u201351.","DOI":"10.1056\/NEJM198501173120303"},{"issue":"3","key":"4046_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-014-3254-6","volume":"149","author":"SW Dyrstad","year":"2015","unstructured":"Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Breast cancer risk associated with benign breast disease: systematic r eview and meta-analysis. Breast Cancer Res Treat. 2015;149(3):569\u201375.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"4046_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"A Garmendia Madariaga","year":"2014","unstructured":"Garmendia Madariaga A, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4046_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301\u201316.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"4046_CR9","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1210\/jc.2016-2104","volume":"101","author":"SR Khan","year":"2016","unstructured":"Khan SR, Chaker L, Ruiter R, Aerts JG, Hofman A, Dehghan A, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab. 2016;101(12):5030\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"4046_CR10","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.canep.2021.101985","volume":"74","author":"PG Advani","year":"2021","unstructured":"Advani PG, Morton LM, Kitahara CM, Berrington de Gonzalez A, Ramin C, Haymart MR, Curtis RE, Schonfeld SJ. Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer. Cancer Epidemiol. 2021;74:101985.","journal-title":"Cancer Epidemiol"},{"key":"4046_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.973161","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Xia L, Li X, He H. Assessing the causality between thyroid and breast neoplasms: a bidirectional Mendelian randomization study. Front Oncol. 2022;12:973161.","journal-title":"Front Oncol"},{"key":"4046_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1138149","volume":"14","author":"H Tan","year":"2023","unstructured":"Tan H, Wang S, Huang F, Tong Z. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1138149.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4046_CR13","doi-asserted-by":"crossref","unstructured":"Birney E. Mendelian Randomization. Cold Spring Harbor perspectives in medicine. 2022;12(4):a041302.","DOI":"10.1101\/cshperspect.a041302"},{"issue":"1","key":"4046_CR14","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1038\/s41467-018-06356-1","volume":"9","author":"A Teumer","year":"2018","unstructured":"Teumer A, Chaker L, Groeneweg S, Li Y, Di Munno C, Barbieri C, et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat Commun. 2018;9(1):4455.","journal-title":"Nat Commun"},{"issue":"7944","key":"4046_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"5","key":"4046_CR16","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26(5):2333\u201355.","journal-title":"Stat Methods Med Res"},{"issue":"22","key":"4046_CR17","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. Phenoscanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851\u20133.","journal-title":"Bioinformatics"},{"issue":"20","key":"4046_CR18","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, Paul DS, Freitag D, Burgess S, Danesh J, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016;32(20):3207\u20139.","journal-title":"Bioinformatics"},{"issue":"10","key":"4046_CR19","doi-asserted-by":"publisher","first-page":"e1003288","DOI":"10.1371\/journal.pmed.1003288","volume":"17","author":"MG Levin","year":"2020","unstructured":"Levin MG, Judy R, Gill D, Vujkovic M, Verma SS, Bradford Y, et al. Genetics of height and risk of atrial fibrillation: a Mendelian randomization study. PLoS Med. 2020;17(10):e1003288.","journal-title":"PLoS Med"},{"issue":"7","key":"4046_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"4046_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"4046_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"6","key":"4046_CR23","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"4046_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and disea ses. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"2","key":"4046_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"4046_CR26","first-page":"1713","volume":"30","author":"N Ditsch","year":"2010","unstructured":"Ditsch N, Liebhardt S, Von Koch F, Lenhard M, Vogeser M, Spitzweg C, Gallwas J, Toth B. Thyroid function in breast cancer patients. Anticancer Res. 2010;30(5):1713\u20137.","journal-title":"Anticancer Res"},{"issue":"9","key":"4046_CR27","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/ijc.27470","volume":"131","author":"A Tosovic","year":"2012","unstructured":"Tosovic A, Becker C, Bondeson AG, Bondeson L, Ericsson UB, Malm J, et al. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer. 2012;131(9):2126\u201333.","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"4046_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsbmb.2007.12.008","volume":"109","author":"LC Hall","year":"2008","unstructured":"Hall LC, Salazar EP, Kane SR, Liu N. Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol. 2008;109(1\u20132):57\u201366.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"4046_CR29","first-page":"1356","volume":"30","author":"M Rasool","year":"2014","unstructured":"Rasool M, Naseer MI, Zaigham K, Malik A, Riaz N, Alam R, et al. Comparative study of alterations in Tri-iodothyronine (T3) and thyroxine (T4) hormone levels in breast and ovarian cancer. Pak J Med Sci. 2014;30(6):1356\u201360.","journal-title":"Pak J Med Sci"},{"issue":"5","key":"4046_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1590\/S0100-879X2005000500014","volume":"38","author":"PP Saraiva","year":"2005","unstructured":"Saraiva PP, Figueiredo NB, Padovani CR, Brentani MM, Nogueira CR. Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res. 2005;38(5):761\u20135.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"4046_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5603\/EP.a2022.0020","volume":"73","author":"Z Lei","year":"2022","unstructured":"Lei Z, Zeng B, Wu L, Deng Q, Guo D. Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis. Endokrynol Pol. 2022;73(2):309\u201315.","journal-title":"Endokrynol Pol"},{"issue":"7","key":"4046_CR32","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/ijc.32988","volume":"147","author":"S Yuan","year":"2020","unstructured":"Yuan S, Kar S, Vithayathil M, Carter P, Mason AM, Burgess S, et al. Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: a two-sample Mendelian randomization study. Int J Cancer. 2020;147(7):1895\u2013903.","journal-title":"Int J Cancer"},{"issue":"4","key":"4046_CR33","doi-asserted-by":"publisher","first-page":"e0122955","DOI":"10.1371\/journal.pone.0122955","volume":"10","author":"FY Tseng","year":"2015","unstructured":"Tseng FY, Lin WY, Li CI, Li TC, Lin CC, Huang KC. Subclinical hypothyroidism is associated with increased risk for cancer mortality in adult Taiwanese-a 10 years population-based cohort. PLoS ONE. 2015;10(4):e0122955.","journal-title":"PLoS ONE"},{"issue":"12","key":"4046_CR34","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/ijc.32283","volume":"145","author":"EY Kim","year":"2019","unstructured":"Kim EY, Chang Y, Lee KH, Yun JS, Park YL, Park CH, et al. Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: a cohort study. Int J Cancer. 2019;145(12):3257\u201366.","journal-title":"Int J Cancer"},{"issue":"12","key":"4046_CR35","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1210\/jc.2016-2104","volume":"101","author":"SR Khan","year":"2016","unstructured":"Khan SR, Chaker L, Ruiter R, Aerts JGJV, Hofman A, Dehghan A, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab. 2016;101(12):5030\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4046_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/EJE-15-0989","volume":"174","author":"M S\u00f8gaard","year":"2016","unstructured":"S\u00f8gaard M, Farkas DK, Ehrenstein V, J\u00f8rgensen JO, Dekkers OM, S\u00f8rensen HT. Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. Eur J Endocrinol. 2016;174(4):409\u201314.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"4046_CR37","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/cncr.20881","volume":"103","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer. 2005;103(6):1122\u20138.","journal-title":"Cancer"},{"issue":"3\u20134","key":"4046_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0960-0760(96)00117-3","volume":"59","author":"CR Nogueira","year":"1996","unstructured":"Nogueira CR, Brentani MM. Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol. 1996;59(3\u20134):271\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"4046_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mc.10046","volume":"34","author":"JM Gonz\u00e1lez-Sancho","year":"2002","unstructured":"Gonz\u00e1lez-Sancho JM, Figueroa A, L\u00f3pez-Barahona M, L\u00f3pez E, Beug H, Mu\u00f1oz A. Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells. Mol Carcinog. 2002;34(1):25\u201334.","journal-title":"Mol Carcinog"},{"issue":"1","key":"4046_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/excr.1995.1124","volume":"218","author":"ZM Shao","year":"1995","unstructured":"Shao ZM, Sheikh MS, Rishi AK, Dawson MI, Li XS, Wilber JF, Feng P, Fontana JA. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation. Exp Cell Res. 1995;218(1):1\u20138.","journal-title":"Exp Cell Res"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-04046-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:32:03Z","timestamp":1760013123000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-04046-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4046"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-04046-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4116246\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Our study is based on open-source data that has obtained approval Ethical approval and informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"481"}}